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We treated a patient with hypertrophic obstructive cardiomyopathy (HOCM) who
underwent DDD pacing therapy. He suﬀered from attacks of paroxysmal atrial ﬁbrillation
(PAF) complicated by sick sinus syndrome. Initially, we were unable to decrease the left
ventricular outﬂow tract (LVOT) gradient by pacing from the mid-distal portion of the right
ventricular (RV) septum. However, by changing the pacing site to the apical portion guided
by right ventriculography, it was possible to decrease the LVOT gradient and at the same time
reduce the mitral regurgitation. Tissue Doppler imaging (TDI) revealed a marked motion
delay of the ventricular septum during DDD pacing. The mechanism of the therapy for
HOCM provided by the DDD pacing was clearly conﬁrmed by TDI. Furthermore, a dramatic
eﬀect of preventing symptomatic PAF with the use of overdrive pacing in the region of
Bachmann’s bundle was also observed. This case report provides new insight into DDD
pacing therapy for patients with HOCM.
(J Arrhythmia 2007; 23: 245–249)
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Introduction
Currently permanent pacemakers should be con-
sidered as an adjunctive therapy for HOCM. Al-
though therapies such as percutaneous myocardial
ablation and surgical manipulation eﬀectively reduce
the LVOT gradient, they carry a risk of mortality and
morbidity.1–3) On the other hand, pacing therapy has
is less invasive than the therapies mentioned above
because it causes no rapid or irreversible anatomical
changes. However, results of recent randomized
studies have not been uniform and are considered
controversial.4)
This case report describes a patient with HOCM
in whom a reduction in the LVOT gradient was
achieved with appropriate insertion of a right
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ventricular (RV) lead guided by a hemodynamic
study. Tissue doppler imaging (TDI) revealed a more
marked motion delay of the ventricular septum
during dual-chamber (DDD) pacing than atrial (AAI)
pacing, and frequent paroxysmal atrial ﬁbrillation
(PAF) attacks were greatly suppressed by overdrive
Bachmann’s bundle pacing.
Case Report
A 62-year-old man with a history of precordial
chest pain during a PAF attack was admitted to our
hospital. Drug therapy including beta-blockers (me-
toprolol 240mg/day), cibenzoline (300mg/day) and
verapamil (120mg/day) could not reduce the LVOT
gradient or suppress the PAF attacks. In the 2 weeks
that followed, he had a pre-syncopal episode. The
ECG demonstrated a sinus pause after the PAF had
terminated. The physical examination revealed a
grade 4/6 systolic murmur, best heard from the apex.
A 12-lead electrocardiogram (ECG) demonstrated
sinus rhythm with left ventricular hypertrophy.
Transthoracic echocardiography revealed asymmet-
ric septal hypertrophy (interventricular septum,
23mm vs. posterior wall, 19mm), systolic anterior
motion of the mitral valve, and moderate mitral
regurgitation (MR). Continuous wave (CW) Doppler
revealed a signiﬁcant dynamic LVOT gradient of
103mmHg. Implantation of a permanent DDD
pacemaker was performed in order to maintain
rhythm and to reduce the LVOT gradient.
During the cardiac catheterization the coronary
arteriogram did not reveal any organic stenosis.
Without discontinuing the oral drugs from the
above description, a hemodynamic study was
performed before the implantation. The left ven-
tricular and aortic pressures were recorded simulta-
neously and the diﬀerence was used as a surrogate
of the LVOT gradient. The LVOT gradient was
maintained (110mmHg) by pacing from the mid-
distal portion of the RV septum (Figure 1). How-
ever, pacing from the apical portion of the RV
guided by right ventriculography (RVG) reduced
the LVOT gradient (to 44mmHg) when the interval
of the atrioventricular delay was set at 100msec
(Figure 2). Changes in the AV delay (from 80 to
150msec) did not inﬂuence the LVOT gradient
with the DDD pacing. After these measurements
were made, separate pacemaker leads were inserted
in the RA septum around Bachmann’s bundle (BB)
and the RV apex region. The RV pacemaker lead, a
model 5068‘CAPSUREFIX’ bipolar screw-in lead
(Medtronic, Inc, Minneapolis, MN, USA), was
advanced to the apical portion of the RV.
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Figure 1 Simultaneous recordings of the left ventricular and aortic pressures.
A: Unpaced, pressure gradient of 113mmHg.
B: Dual chamber (DDD) pacing, with the right ventricular (RV) catheter located in the mid-distal portion of the RV septum, pressure
gradient of 110mmHg.
C: The RV catheter is located in the mid-distal portion of the RV septum.
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An echocadiographic examination performed 2
weeks after the pacemaker implantation revealed
that the LVOT gradient was 38mmHg and there was
a mild degree of MR. All echocardiographic meas-
urements were obtained using the Vivid 7 echocar-
diographic scanner (GE-Vingmed Ultrasound AS,
Horten, Norway) with a 2.5-MHz transducer. We
recorded TDI images of the 4-chamber views with
AAI and DDD pacing, respectively. At least 3
consecutive beats were stored digitally for post-
processing. The gain settings, ﬁlters, and pulse
repetition frequency were adjusted to optimize the
color saturation. The TDI data were analyzed using
the software program provided with the echocardio-
graphic machine (Tissue Tracking mode). TDI
clearly revealed a motion change in the ventricular
septum during DDD pacing rather than during AAI
pacing (Figure 3).
After three-weeks of follow-up, the patient con-
tinued to have symptomatic PAF. Overdrive pacing
in the region of BB (DDD minimum HR:75bpm)
could suppress the symptomatic episodes of the
PAF, detected by the device-monitored diagnostics
(Figure 4). After six-months of follow-up, the patient
has remained asymptomatic.
Discussion
The key ﬁndings in the present case were as
follows: (1) The ﬁrst observation in this study was
that a reduction in the pressure gradient was not
achieved with the RV septal pacing; (2) The optimal
RV pacing site guided by the RVG and hemody-
namic study could improve the LVOT gradient with
a reduction in the MR; (3) The overdrive BB pacing
could prevent symptomatic PAF.
DDD pacing has been reported to be eﬀective in
HOCM patients by altering the pattern of the septal
contraction and causing a delay in the onset of the
mitral leaﬂet movement and septal contraction during
right ventricular stimulation.5) In our patient, the
indication for permanent pacemaker implantation
was sick sinus syndrome. It was very important to
choose an eﬀective pacing site in order to decrease the
LVOT gradient. The cardiac apex should be visual-
ized with contrast by RVG because an overhang of the
ventricular septum often makes positioning of the RV
lead diﬃcult. Further, the RV lead should certainly be
inserted guided by a hemodyanamic study to acquire
the greatest eﬀect of this therapy. The selection of
the pacing site needs to be carefully evaluated.
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Figure 2 Simultaneous recordings of the left ventricular and aortic pressures.
A: Unpaced, pressure gradient of 103mmHg.
B: DDD pacing with the RV lead located in the apical portion of the RV, pressure gradient of 44mmHg.
C: Right ventriculography (RVG) showing the true RV apex.
D: The screw-in lead is located in the apical portion of the RV. PM, pacemaker.
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Figure 3 Tissue Doppler imaging (Upper), 2-D color Doppler echocardiography (Lower) and continuous wave Doppler
echocardiography (Lower) were recorded 1 month after the pacemaker implantation. The tissue Doppler images were recorded
from the 4-chamber view with AAI and DDD pacing. The Doppler points (yellow, light blue) are positioned at the basal- and mid-
septum, and the others (green, red) at the basal- and mid-lateral wall. TDI clearly revealed a greater motion delay in the
ventricular septum during DDD pacing rather than during AAI pacing. The pressure gradient at the LVOT decreased from
123mmHg to 38mmHg. Note that the mitral regurgitation area visualized during the DDD pacing is dramatically reduced
compared to that during AAI pacing (lower).
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Figure 4 Overdrive pacing in the region of
Bachmann’s bundle could suppress the symp-
tomatic episodes of PAF, detected by device-
monitored diagnostics.
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TDI has been used to assess the regional cardiac
function and synchrony before and after pacing.6)
Recently, Ito et al.7) reported the eﬃcacy of TDI for
DDD pacing therapy in HOCM. In our case, TDI
revealed a more marked motion delay in the
interventricular septum during DDD pacing than it
did during AAI pacing (Figure 3). This mechanism
could be explained by the following. At ﬁrst, the
interventricular septum contracted earlier during the
pacing stimulation than did the lateral wall (Figure 3
right upper panel), but the septum could not contract
longitudinally due to its hypertrophy, and therefore
the lateral wall contracted earlier than the septum.
The dyssynchrony, that is to say the septum
contraction during the early diastolic phase, was
caused by the delayed longitudinal contraction that
Sogaard et al. reported.8) We also found that DDD
pacing reduced the MR in comparison to AAI
pacing. The possibility was suggested that by
directly altering the mitral valve complexes or
improving the mitral valve systolic anterior move-
ment by decreasing the Venturi eﬀect, a reduction in
the MR could be achieved (Figure 3).
Atrial ﬁbrillation (AF) is the major cardiac
arrhythmia in severe HOCM. The eﬀect of BB
pacing and overdrive pacing in the prevention of
symptomatic PAF was reported.9,10) In the present
case, the frequent PAF attacks were greatly sup-
pressed by overdrive pacing in the BB region
(Figure 4). The possibility of the synergistic eﬀect
of the reduction in the MR is also suggested. To the
best of our knowledge, there have been no reports
in which overdrive pacing in the BB region could
suppress symptomatic episodes of PAF in HOCM.
This therapy could serve a dual purpose, by provid-
ing a hemodynamic eﬀect and preventing atrial
tachyarrhythmias.
Pacing therapy may demonstrate a signiﬁcant
advantage over the other therapies in that a detailed
hemodynamic study can be performed before the
implantation, and the use of various drugs can be
increased in the presence of bradycardia after the
implantation. Further studies may be necessary in
order to establish this therapy. We believe this
‘‘cardiac desynchronization therapy’’ for HOCM has
further possibilities.
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